Inguinal endometriosis is rare and accounts for 0.3% to 0.6% of all cases of endometriosis. Although a few studies have described drug therapy for this condition, inguinal endometriosis is primarily treated surgically. We report a case of i…
PURPOSE: Relugolix is an oral gonadotropin-releasing hormone antagonist (GnRHant), which was first introduced in 2019. This study investigated the effects of the conventional injectable GnRHant formulation and this new oral GnRHant formulat…
PURPOSE: The aim of this study was to determine the prophylactic effects of cabergoline on ovarian hyperstimulation syndrome (OHSS) after oocyte retrieval. METHODS: A total of 187 women underwent controlled ovarian stimulation using gonado…
BACKGROUND: Xanthogranulomatous inflammation is an uncommon form of chronic inflammation that is destructive to the normal tissue of affected organs. Although xanthogranulomatous endometritis and xanthogranulomatous salpingitis of the femal…